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The sequence of the 3’-terminal 565 nucleotides of yellow fever virus has been determined from a cloned 
cDNA. Several structures are detectable: three tandemly repeated sequences, a series of inverted repeats 
and a stable secondary structure involving the 3’-terminal 120 nucleotides. 
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1. INTRODUCTION 2.2. Synthesis and cloning of cDNA 
Yellow fever virus (YF); a mosquito borne virus, 
belonging to the Flaviviridae family, is able to 
replicate in both arthropod and vertebrate cells. Its 
genome is a single-stranded RNA molecule of 
positive polarity (review [I ,2]), approx. 11000 
bases long, which lacks a 3 ‘-poly(A) sequence [3]. 
Cloned cDNA copies of the YF RNA could be 
powerful tools to study the regulatory mechanisms 
involved in the expression of the viral genome and 
to understand the basis of YF virulence. 
Here we report the isolation and the nucleotide 
sequence of a cDNA copy corresponding to the 
3 ‘-end of the viral RNA of the vaccinal strain 
17D.204 [4]. 
When not quoted- we have used current pro- 
cedures reviewed by Maniatis et al. [5]. 
2. MATERIALS AND METHODS 
2.1. Purification of the viral RNA 
YF strain 17 D 204 (236th passage) was grown in 
SW 13 cells. The virus and its RNA were purified as 
described [4]. 
The RNA preparation was polyadenylated as 
described [6] following denaturation with 10 mM 
methylmercury hydroxide (CHsHgOH). The syn- 
thesis of cDNA was performed using AMV reverse 
transcriptase in the presence of oligo(dT). After 
second strand synthesis and nuclease Sl treatment, 
double-stranded cDNA was tailed with oligo(dC) 
and hybridized to oligo(dG) tailed pBR 322, cut at 
the PstI site. The mixture was used to transform 
calcium chloride treated E. coli HBlOl [7] cells. 
The in situ hybridization of the library was per- 
formed with YF RNA, which was further purified 
on low melting temperature agarose gel and 
fragmented during extraction from the gel slice by 
partial alkaline hydrolysis. The RNA fragments 
were 5 ‘-labeled with polynucleotide kinase and 
[y-32P]ATP. Nucleotide sequencing was per- 
formed according to Maxam and Gilbert [8]. 
2.3. Ribonuclease T2 mapping 
+ Present address: Institut Jacques Monod (CNRS), Unite IN- 
SERM 257, UniversitC Paris 7, Tour 43,2 Place Jussieu, 75251 
Paris Cedex 05, France 
YF RNA was 3’-labeled with [32P]pCp and 
RNA ligase [9] after denaturation with CH3HgOH. 
The labeled RNA was hybridized with the purified 
cDNA insert and after ethanol precipitation, the 
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hybrids were subjected to ribonuclease T2 diges- 
tion. The products were analysed on CHJHgOH 
agarose gels. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of YF cDNA clones 





Fig. 1. Analysis of the products of polyadenylation of YF 
RNA on CH3HgOH agarose (1070) gel. The polyadenyla- 
tion reaction was performed as described [6] with the 
following modification. After denaturation, 5 pg YF 
RNA were incubated for 15 min at 37°C in a reaction 
mixture of 50 ~1 containing 10 U E. co/i poly(A) 
polymerase (BRL) and 10 &i [Y~~P]ATP. Slot 1: the 
denaturing agent (CH3HgOH) was complexed with p- 
mercaptoethanol just before (less than 1 s) the reaction 
mixture was added. Slot 2: the reaction mixture was add- 
ed about 15 s after addition of the complexing agent. 
The same amount of trichloroacetic acid precipitable 
radioactivity (5000 cpm) has been loaded on each slot. 
quence data available when we initiated this work 
was the identity of the 3 ‘-terminal nucleotide of 
the viral genome: a uracil [3]. Thus we chose to 
add, in vitro, a poly(A) tail at the 3 ‘-end of the 
RNA to prime the synthesis of the first cDNA 
strand with oligo(dT). 
Previous experiments pointed out the low ac- 
cessibility of this 3 ‘-end to enzymatic modifica- 
tion, probably because of the secondary structure 
of the molecule [3]. Thus, the intact RNA molecule 
was denatured with methylmercury hydroxide 
prior to the polyadenylation reaction. The dena- 
turing agent was complexed just before addition to 
the reaction mixture. In spite of this treatment, YF 
RNA was not polyadenylated as efficiently as 
minor amounts of contaminating RNA molecules 
(fig. 1). 
This polyadenylated RNA was used as a template 
for cDNA synthesis using oligo(dT) as a primer. A 
cDNA library of 1200 bacterial clones was ob- 
tained. To identify YF specific clones, in situ 
hybridization of the library was performed with 
5 ’ -labeled fragmented YF RNA. Three clones gave 
a positive signal with this probe. The largest cDNA 
containing plasmid, pYF1, was shown to hybridize 
with YF RNA on a Northern blot and so was fur- 
ther studied. 
3.2. Characterization of a cDNA clone 
corresponding to the 3 ‘-end of the viral RNA 
The cDNA insert of the plasmid pYF1 was se- 
quenced according to the procedure of Maxam and 
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Fig.2. Restriction mapping of the cloned cDNA and 
strategy for nucleotide sequence determination. The 
cDNA is oriented in the 5 ’ to 3 ’ direction relative to the 
vRNA. Only the restriction cleavage sites used for DNA 
sequencing are shown. A, AluI; H, NpaII; P, PstI; M, 
MboII; D, DdeI. Arrows indicate length and direction 
of DNA sequences analysed. Arrows above and below 
the restriction map indicate, respectively, that viral and 
complementary strands were sequenced. The thick part 
of the map indicates the cDNA fragments used for 
primer extension analysis. 
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Fig.3. Nucleotide sequence of the cloned cDNA strand corresponding to the viral RNA. The tracts of dG and dC at 
the 5 ’ - and 3 ‘-end, respectively, were generated uring the cloning procedure. The tract of dA preceding the dC tract 
was generated uring the polyadenylation of the viral RNA. The stretches of nucleotides (l-3) underlined by plain ar- 
rows correspond to the 3 direct repeats. The nucleotides marked with a dot are not identical in all these repeats. The 
stretches of nucleotides (a,a’-g,g’) underlined by dotted arrows correspond to the inverted repeats. Only the inverted 
repeats longer than 4 nucleotides, spaced by less than 15 nucleotides and localized upstream from the region correspon- 
ding to the 3’-terminal 120 nucleotides of the viral RNA are figured. 
Gilbert [8] following the strategy shown in fig.2. 
The resulting nucleotide sequence is shown in 
fig.3. 
Due to the strategy employed for cDNA syn- 
thesis, the DNA strand corresponding to the 
positive (or sense) viral RNA should carry a 
3 ‘-poly(dA) tract. The sequence of the pYF1 insert 
indicates the presence of such a dA tract on one 
DNA strand, thus allowing a putative identifica- 
tion of the positive strand. To test this assignation, 
the 2 strands of a 266 bp long restriction fragment 
generated by H&II cleavage of the cloned cDNA 
(fig.2) were separated, sequenced and used as 
primers for reverse transcription of the viral RNA. 
As expected, only 1 of the 2 strands could be used 
as a primer, namely the previously assigned 
negative strand. More than 10 different cDNA 
products of discrete size could be detected as the 
result of the primer extension reaction (fig.4). 
Premature termination of cDNA synthesis at 
defined sites of a RNA molecule has been de- 
scribed [lo] and it seems likely that this is the case 
here as the amount of products decreases with in- 
creasing size. As it is not possible to ascertain that 
the largest primer extension product detectable is a 
cDNA molecule which has been elongated to the 
5 ’ -end of the viral RNA, these data do not allow 
the localization of pYF1 cDNA on the viral 
genome. However, 2 features suggest that this 
cDNA corresponds to the 3 ‘-end of YF RNA: (i) 
the poly(dA) tract at the 3’-end of the positive 
viral DNA strand, which should have been gener- 
ated during the polyadenylation step of the viral 
RNA; (ii) the presence of a thymidine residue just 
preceding this poly(dA) tract which is in agreement 
with the fact that a uracil is the 3’ ultimate nucleo- 
tide of YF RNA [3]. 
We confirmed the localization of the pYF1 in- 
sert by its ability to protect 3 ‘-labeled YF RNA 
from ribonuclease T2 treatment. Such protection 
shows also that pYFl cDNA has retained the 
overall structure of the 3’-end of YF RNA. 
3.3. Characteristics op the nucleotide sequence 
of the 3 ‘-end of the YF RNA 
In the 3 possible reading frames, there are at 
least 6 translational stops and at least one in the 5 ’ 
125 nucleotides of the insert. Although it is not yet 
possible to localize the end of the coding region of 
the genome the sequence data indicate that the last 
440 nucleotides of the viral RNA are noncoding. 
The nucleotide sequence reported here reveals 
some interesting structural features of the 3 ‘-end 
of YF RNA. A stretch of 41 nucleotides (under- 
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Fig.4. Analysis of the products of reverse transcription 
of YF RNA from a cloned primer on alkaline agarose 
(lolo) gel. Slot 1: size marker, 3 ‘-labeled EcoRI + Hin- 
dIII cleaved DNA. Slot 2: primer extension product syn- 
thesized as follows: the 2 strands of a 266 bp HpaII 
restriction fragment (fig.2) were separated. After 
5 ’ -labeling with [Y-~*P]ATP the strand complementary 
to the viral RNA was mixed with the viral RNA before 
denaturation. The reverse transcriptase (Anglian 
Biotech) directed synthesis of cDNA was then performed 
as described [S] without addition of oligo(dT) and label- 
ed dNTP. 
lined by plain arrows in fig.3) is repeated 3 times 
in this part of the genome with only 4 variable 
positions in the 3 repeats. Following these direct 
repeats there is a series of inverted repeats (under- 
lined by dotted arrows in fig.3) which might be in- 
volved in a secondary structure of the stem loop 
type. 
In the 3 ‘-terminal 120 nucleotides there are long 
stretches of complementary sequences. Computer 
Fig.5. Representation f the most stable (A Go= -52 
kcal/mol) secondary structure adoptable by the 
3 ‘-terminal 120 nucleotides of the YF RNA as predicted 
by computer program analysis [l 11. 
program analysis [l l] allows the prediction of 
many slightly different stable secondary structures 
(A Go< -40 kcal/mol). The most stable one (A 
GO = - 52 kcal/mol), for which two thirds of these 
nucleotides are base paired, has been represented 
(fig.5). 
All these stable conformations have a feature in 
common: the 5 terminal nucleotides at the 3 ‘-end 
form part of a base paired structure. Such sec- 
ondary structures might therefore account for the 
low reactivity of the 3 ‘-end observed during our 
attempts to modify it enzymatically. One might 
speculate that the 3’-end of pYF RNA is also a 
poor substrate for cytoplasmic exonucleases. Such 
a secondary structure could therefore have an ef- 
fect on RNA stability similar to the 3 ’ -poly(A) tail 
of eukaryotic mRNA [12]. 
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Stable secondary structures are also likely to ex- 
ist at multiple sites elsewhere in the genome and 
could be responsible for the preferential stops 
observed during reverse transcription of the viral 
RNA. More nucleotide sequence data are neces- 
sary to test this hypothesis, and isolation of cDNA 
clones covering the entire genome is currently 
under way. They should help in determining the 
function of the different region of the viral genome 
and in analyzing the biological significance of 
these secondary structures. 
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